The Italian leader told reporters friday that he believed the EU’s export mechanism deserves to be used “especially towards corporations that do not comply with the agreements. “Draghi did not mention any name from express pharmaceutical corporations, but said some vaccine manufacturers “sell doses twice” to more than one country.
He said, “It turns out that some companies, and I won’t call calls, have sold things two or three times. “
The accusation comes when the EU has been involved in a bitter dispute with the UK and AstraZeneca vaccine providers.
Tensions with the UK over vaccine exports increased when European Commission President Ursula von der Leyen threatened the UK with an export ban.
On Saturday, the Times reported that the UK is now close to concluding a vaccine deal with the EU as early as this weekend, which points to the risk of the bloc cutting supplies.
Under the agreement, the EU will run the risk of banning the export of Pfizer-BioNTech vaccines to Britain, he added.
In return, the UK government will agree to give up some long-term oxford-AstraZeneca vaccine materials to be exported from a plant in the Netherlands through the AstraZeneca subcontractor, Halix, the newspaper reported.
However, the EU has never threatened to ban the export of vaccines, but has only stated that it can block shipments of express vaccines to countries with higher vaccination rates or exporting vaccines to the EU on a case-by-case basis.
A European Commission source said Saturday: “We are at the beginning of discussions with the UK. There are no discussions this weekend. “
READ ALSO: Eurozone crisis: EU vaccine disaster will be block 123 billion euros
They added that sending vaccines produced to Halix is not part of the discussion.
At one point, an EU source had stated in the past that the EU did not aim to share with Britain the substance of the halix vaccine, which it would have already produced enough for around 15 to 20 million doses, and can produce the equivalent of five million doses depending on the month. . .
The UK government, Pfizer-BioNTech and AstraZeneca were not available without delay for comment.
The EU’s rejection follows Britain’s repeated refusal to share with Brussels the doses of AstraZeneca produced at two UK plants.
NOT MANQUER: Fury when Guy Verhofstadt takes a hit in the UK to distract himself from the EU [VIDEO] The UK ridicules French risk of vaccine dose in the UK [INSIGHT] Brexit live: Britain will tell EU that AstraZeneca jab would exist [BLOG LIVE]
On Friday, the European Medicines Agency approved production of Halix in the Netherlands that manufactures the AstraZeneca vaccine and a facility in Marburg, Germany that generates BioNTech/Pfizer injections.
EU vaccination cleanup occurs when the EU counts on it to increase deliveries at the time of the quarter and accelerate the slow pace of vaccines in the block.
The complicated deployment of vaccines in Europe has led to a dispute with Britain, which has imported 21 million EU-made doses, according to an EU official, who says it has been more successful in negotiating with brands and organizing chain of origin.
The EU says Britain has one more percentage, in components to help fill the gap in contract deliveries of AstraZeneca shells.
Brussels and London sought to ease tensions on Wednesday, saying they were working “to create a scenario of mutual benefit and expand vaccines for all our citizens. “
More than 107,000 people have died from COVID-19 in Italy, the highest number in Europe after Britain, and the country continues to record a lot of deaths every day.
Italy has a strong anti-vaccination motion and Draghi said other people running in the fitness sector would be subject to sanctions if they rejected a vaccine. He said he was hoping to get an injection of AstraZeneca next week.